Sant Joan de Deu Health Park
If you are the contact person for this centre and you wish to make any changes, please contact us.
SMC participants
Psychiatrist and principal researcher at Parc Sanitari Sant Joan de Deu and Fundació de Recerca Sant Joan de Deu and secretary of the Spanish Society of Psychedelic Medicine
Contents related to this centre
A dose of psilocybin—a hallucinogenic substance—administered to groups of 3 or 4 people suffering from cancer and depression may help reduce their depressive symptoms, according to a clinical trial conducted in the United States. The study involved 30 patients who also received individual and group therapeutic support. In another article, also published in the journal Cancer, the authors examine how the study participants perceived the therapy.